Kaposi’s sarcoma remains one of the most common cancers in people living with HIV. Kaposi’s sarcoma usually appears as lesions on the skin or on mucosal surfaces (like inside the mouth or genitals).

There are no at-home tests able to check for Kaposi sarcoma. However, KS can often be recognized by the characteristic lesions that can develop on the skin or in the mouth. KS often starts as flat ...

Different amounts and organization of these two major cellular components were found in all stages of evolution of Kaposi's sarcoma lesions. Immunohistochemical and electron-microscopic techniques ...

Originally published in the Mercury's sister publication The Stranger, as part of its Love & Sex Issue.] On July 3, 1981, the ...

Patients with HIV infection are at an increased risk of a number of malignancies, including Kaposi's sarcoma (KS) and certain B-cell lymphomas. Most of these tumors are caused by oncogenic DNA ...

The most significant adverse event of rituximab therapy for HIV–MCD is Kaposi sarcoma progression. Further work is required to increase our understanding of the disease process to help refine ...

The Kaposi's sarcoma-associated herpesvirus is the causative agent of primary effusion lymphoma (PEL), for which cytotoxic chemotherapy represents the standard of care. The high mortality ...

Immune checkpoint inhibitors (ICIs) have transformed cancer therapy by targeting key immune pathways such as PD-1, PD-L1, CTLA-4, and LAG-3 to enhance the immune system's ability to combat ...